The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•15 April 2026•

1 min read

Analyst Moves: Price Target Cuts for FROG, DT, PODD While Maintaining Buy Ratings

Stylized metallic devices with 'Lilly' and 'SCYNEXIS PHARMACEUTICALS' logos, surrounded by scientific equipment, molecular structures, and data charts on a golden background.

Key Facts

1TD Cowen cut its price target for JFrog (FROG) to $70 from $80, while maintaining a Buy rating.

2TD Cowen cut its price target for Dynatrace (DT) to $50 from $60, while maintaining a Buy rating.

3Truist cut its price target for Insulet (PODD) to $315 from $360, while maintaining a Buy rating.

Major research firms have issued updates to their price targets for several stocks while maintaining their positive recommendations. TD Cowen lowered its price target for software company JFrog (FROG) to $70 from $80. It also cut the target for Dynatrace (DT) to $50 from $60, while keeping a Buy rating on both stocks. Separately, Truist reduced its price target for Insulet (PODD) to $315 from $360, while maintaining its Buy recommendation. These cuts are primarily driven by valuation adjustments following recent declines in the share prices. Analysts emphasize that the moves do not reflect a change in their fundamentally positive view of these companies' growth prospects. The ultimate recommendation for investors remains Buy, despite the near-term downward revisions to price targets.